[1] Sullivan JK, Huizinga J, Edwards RR, et al.Cost-effectiveness of duloxetine for knee OA subjects: the role of pain severity[J]. Osteoarthritis Cartilage, 2021, 29(1): 28-38. [2] Liu W, Guo NY, Wang JQ, et al.Osteoarthritis: mechanisms and therapeutic advances[J]. MedComm(2020), 2025, 6(8): e70290. [3] Tang S, Zhang C, Oo WM, et al.Osteoarthritis[J]. Nat Rev Dis Primers, 2025, 11(1): 10. [4] Shangguan L, Ding M, Wang Y, et al.Denosumab ameliorates osteoarthritis by protecting cartilage against degradation and modulating subchondral bone remodeling[J]. Regen Ther, 2024, 27: 181-190. [5] Wen P, Liu L.Functions of macrophages, T cells, and neutrophils in the synovial microenvironment of osteoarthritis[J]. J Inflamm Res, 2025, 18: 15671-15686. [6] Ansari MM, Ghosh M, Lee DS, et al.Senolytic therapeutics: an emerging treatment modality for osteoarthritis[J]. Ageing Res Rev, 2024, 96: 102275. [7] Liao Z, Cai X, Zheng Y, et al.Sirtuin 1 in osteoarthritis: perspectives on regulating glucose metabolism[J]. Pharmacol Res, 2024, 202: 107141. [8] Zhang K, Wang Z, He J, et al.Mechanisms of synovial macrophage polarization in osteoarthritis pathogenesis and their therapeutic implications[J]. Front Immunol, 2025, 16: 1637731. [9] Jang S, Lee K, Ju JH.Recent updates of diagnosis, pathophysiology, and treatment on osteoarthritis of the knee[J]. Int J Mol Sci, 2021, 22(5): 2619. [10] Cao H, Li W, Zhang H, et al.Bio-nanoparticles loaded with synovial-derived exosomes ameliorate osteoarthritis progression by modifying the oxidative microenvironment[J]. J Nanobiotechnology, 2024, 22(1): 271. [11] Allis CD, Jenuwein T.The molecular hallmarks of epigenetic control[J]. Nat Rev Genet, 2016, 17(8): 487-500. [12] Grandi FC, Bhutani N.Epigenetic therapies for osteoarthritis[J]. Trends Pharmacol Sci, 2020, 41(8): 557-569. [13] Kiełbowski K, Herian M, Bakinowska E, et al.The role of genetics and epigenetic regulation in the pathogenesis of osteoarthritis[J]. Int J Mol Sci, 2023, 24(14): 11655. [14] Kamenaga T, Shen J, Wu M, et al.Epigenetic dysregulation of articular cartilage during progression of hip femoroacetabular impingement disease[J]. J Orthop Res, 2023, 41(8): 1678-1686. [15] Xiong S, Zhao Y, Xu T.DNA methyltransferase 3 beta mediates the methylation of the microRNA-34a promoter and enhances chondrocyte viability in osteoarthritis[J]. Bioengineered, 2021, 12(2): 11138-11155. [16] Lv Z, Cai X, Bian Y, et al.Advances in mesenchymal stem cell therapy for osteoarthritis: from preclinical and clinical perspectives[J]. Bioengineering(Basel), 2023, 10(2): 195. [17] Izda V, Dunn CM, Prinz E, et al.A pilot analysis of genome-wide DNA methylation patterns in mouse cartilage reveals overlapping epigenetic signatures of aging and osteoarthritis[J]. ACR Open Rheumatol, 2022, 4(12): 1004-1012. [18] Lin R, Yin J, Huang J, et al.Macrophage-derived ectosomal miR-350-3p promotes osteoarthritis progression through downregulating chondrocyte H3K36 methyltransferase NSD1[J]. Cell Death Discov, 2024, 10(1): 223. [19] Luo JF, Zhou H, Lio CK.Akebia Saponin D inhibits the inflammatory reaction by inhibiting the IL-6-STAT3-DNMT3b axis and activating the Nrf2 pathway[J]. Molecules, 2022, 27(19): 6236. [20] Chen C.Searching for intellectual turning points: progressive knowledge domain visualization[J]. Proc Natl Acad Sci U S A, 2004, 101(Suppl 1): 5303-5310. [21] Chen C.CiteSpace II: detecting and visualizing emerging trends and transient patterns in scientific literature[J]. J Am Soc Inf Sci Technol, 2006, 57(3): 359-377. [22] Chen C, Kuljis J.The rising landscape: a visual exploration of superstring revolutions in physics[J]. J Am Soc Inf Sci Technol, 2003, 54(5): 435-446. [23] Chen C, Ibekwe-SanJuan F, Hou J. The structure and dynamics of cocitation clusters: a multiple-perspective cocitation analysis[J]. J Am Soc Inf Sci Technol, 2010, 61(7): 1386-1409. [24] Shen J, Wang C, Li D, et al.DNA methyltransferase 3b regulates articular cartilage homeostasis by altering metabolism[J]. JCI Insight, 2017, 2(12): e93612. [25] 徐涛涛. 苦杏仁苷调控软骨细胞p38/MAPK/Dnmt3b信号通路延缓关节软骨退变的机制研究[D]. 杭州: 浙江中医药大学, 2018. Xu TT.Mechanism study on amygdalin regulating the p38/MAPK/Dnmt3b signaling pathway in chondrocytes to delay articular cartilage degeneration[D]. Hangzhou: Zhejiang Chinese Medicine University, 2018. [26] Dou P, He Y, Yu B, et al.Downregulation of microRNA-29b by DNMT3B decelerates chondrocyte apoptosis and the progression of osteoarthritis via PTHLH/CDK4/RUNX2 axis[J]. Aging (Albany NY), 2020, 13(5): 7676-7690. [27] Shen J, Wang C, Ying J, et al.Inhibition of 4-aminobutyrate aminotransferase protects against injury-induced osteoarthritis in mice[J]. JCI Insight, 2019, 4(18): e128568. [28] Atsumi T, Suzuki H, Jiang JJ, et al.Rbm10 regulates inflammation development via alternative splicing of Dnmt3b[J]. Int Immunol, 2017, 29(12): 581-591. [29] Zhou Y, Chen M, O'Keefe RJ, et al. Epigenetic and therapeutic implications of Dnmt3b in temporomandibular joint osteoarthritis[J]. Am J Transl Res, 2019, 11(3): 1736-1747. [30] Kim D, Song J, Han J, et al.Two non-coding RNAs, MicroRNA-101 and HOTTIP contribute cartilage integrity by epigenetic and homeotic regulation of integrin-α1[J]. Cell Signal, 2013, 25(12): 2878-2887. [31] Duarte-Olivenza C, Antonio Montero J, Ignacio Lorda-Diez C. Effects of berberine on the chondrogenic differentiation of embryonic limb skeletal progenitors[J]. J Inflamm Res, 2021, 14: 5001-5011. [32] Nam EJ, Kim KH, Han SW, et al.The -283C/T polymorphism of the DNMT3B gene influences the progression of joint destruction in rheumatoid arthritis[J]. Rheumatol Int, 2010, 30(10): 1299-1303. [33] Shu K, Kuang N, Zhang Z, et al.Therapeutic effect of daphnetin on the autoimmune arthritis through demethylation of proapoptotic genes in synovial cells[J]. J Transl Med, 2014, 12: 287. [34] Zhong X, Peng Y, Yao C, et al.Association of DNA methyltransferase polymorphisms with susceptibility to primary gouty arthritis[J]. Biomed Rep, 2016, 5(4): 467-472. [35] Miranda-Duarte A, Borgonio-Cuadra VM, González-Huerta NC, et al.DNA methyltransferase genes polymorphisms are associated with primary knee osteoarthritis: a matched case-control study[J]. Rheumatol Int, 2020, 40(4): 573-581. [36] Ghavidel AA, Shiari R, Hassan-Zadeh V, et al.The expression of DNMTs is dramatically decreased in peripheral blood mononuclear cells of male patients with juvenile idiopathic arthritis[J]. Allergol Immunopathol (Madr), 2020, 48(2): 182-186. [37] Wang B, Sun Y, Liu H, et al.Evaluation of relationship between DNA methyltransferase 3 β gene and the risk of hip osteoarthritis: a case-control study based on a Han Chinese population[J]. Int J Rheum Dis, 2020, 23(10): 1404-1411. [38] Chen X, Zhu X, Wei A, et al.Nrf2 epigenetic derepression induced by running exercise protects against osteoporosis[J]. Bone Res, 2021, 9(1): 15. [39] Liebold I, Grützkau A, Göckeritz A, et al.Peripheral blood mononuclear cells are hypomethylated in active rheumatoid arthritis and methylation correlates with disease activity[J]. Rheumatology (Oxford), 2021, 60(4): 1984-1995. [40] Pascual-Garrido C, Kamenaga T, Brophy RH, et al.Otto Aufranc award: identification of key molecular players in the progression of hip osteoarthritis through transcriptomes and epigenetics[J]. J Arthroplasty, 2022, 37(7S): S391-S399. [41] Sarkar A, Liu NQ, Magallanes J, et al.STAT3 promotes a youthful epigenetic state in articular chondrocytes[J]. Aging Cell, 2023, 22(2): e13773. [42] Bu Y, Wu H, Deng R, et al.Geniposide restricts angiogenesis in experimentary arthritis via inhibiting Dnmt1-mediated PTEN hypermethylation[J]. Int Immunopharmacol, 2022, 111: 109087. [43] Towiwat P, Chhana A, Dalbeth N.The anatomical pathology of gout: a systematic literature review[J]. BMC Musculoskelet Disord, 2019, 20(1): 140. [44] Jiang Y, Shi J, Di W, et al.Mesenchymal stem cell-based therapies for temporomandibular joint repair: a systematic review of preclinical studies[J]. Cells, 2024, 13(11): 990. [45] Kawarai Y, Nakamura J, Hagiwara S, et al.Alterations in DNA methylation machinery in a rat model of osteoarthritis of the hip[J]. J Orthop Surg Res, 2024, 19(1): 357. [46] Kamenaga T, Shen J, Wu M, et al. Poster 112: epigenetic dysregulation during the OA progression in hip FAI[J]. Orthop J Sports Med, 2023, 11(7 suppl 3): 2325967123S00102. [47] Kamenaga T, Shen J, Wu M, et al. Poster 196: articular chondrocytes in hip femoroacetabular impingement present a less catabolic phenotype than late stage of disease[J]. Orthop J Sports Med, 2022, 10(7 suppl 5): 2325967121S00757. [48] Rice SJ, Beier F, Young DA, et al.Interplay between genetics and epigenetics in osteoarthritis[J]. Nat Rev Rheumatol, 2020, 16(5): 268-281. [49] Ootake T, Ishii T, Sueishi K, et al.Effects of mechanical stress and deficiency of dihydrotestosterone or 17β-estradiol on temporomandibular joint osteoarthritis in mice[J]. Osteoarthritis Cartilage, 2021, 29(11): 1575-1589. [50] Longo UG, Papalia R, De Salvatore S, et al.Induced models of osteoarthritis in animal models: a systematic review[J]. Biology (Basel), 2023, 12(2): 283. [51] Zaki S, Smith MM, Smith SM, et al.Differential patterns of pathology in and interaction between joint tissues in long-term osteoarthritis with different initiating causes: phenotype matters[J]. Osteoarthritis Cartilage, 2020, 28(7): 953-965. [52] Obeidat AM, Ishihara S, Li J, et al.Intra-articular sprouting of nociceptors accompanies progressive osteoarthritis: comparative evidence in four murine models[J]. Front Neuroanat, 2024, 18: 1429124. [53] Xie P, Sun AR, Gao F, et al.Resolving microenvironment complexity and cellular heterogeneity in osteoarthritis via spatial transcriptomics[J]. Osteoarthritis Cartilage, 2026, 34(3): 332-342. [54] Adam AO, Benea HRC, Fotescu HM, et al.Recent trends in adipose tissue-derived injectable therapies for osteoarthritis: a scoping review of animal models[J]. Medicina (Kaunas), 2024, 60(5): 707. [55] Resta S, Bardi E, D'Arrigo D, et al. Gut microbiota-targeted interventions for gut-joint axis modulation in experimental osteoarthritis: a systematic review of animal studies[J]. J Funct Foods, 2025, 135: 107078. [56] Tong L, Yu H, Huang X, et al.Current understanding of osteoarthritis pathogenesis and relevant new approaches[J]. Bone Res, 2022, 10(1): 60. [57] Núñez-Carro C, Blanco-Blanco M, Villagrán-Andrade KM, et al.Epigenetics as a therapeutic target in osteoarthritis[J]. Pharmaceuticals (Basel), 2023, 16(2): 156. [58] Veronesi F, Costa V, Bellavia D, et al.Epigenetic modifications of MiRNAs in osteoarthritis: a systematic review on their methylation levels and effects on chondrocytes, extracellular matrix and joint inflammation[J]. Cells, 2023, 12(14): 1821. |